OACCW
Oaktree Acquisition Corp. III Life Sciences
Key Financials
Net Income
$7.3M
↑ 447.3%
Operating Income
$-1195687
↓ 239.9%
Total Assets
$203.1M
↑ 4.0%
Cash & Equivalents
$1.4M
↑ 5.7%
Total Liabilities
$8.3M
↑ 7.4%
Shareholders' Equity
$-6770157.00
↓ 11.5%
Operating Cash Flow
$-422079.00
↓ 370.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 3/26/2026 | View on SEC |
| SCHEDULE 13G/A | 2/11/2026 | View on SEC |
| 10-Q | 11/13/2025 | View on SEC |
| 3 | 10/29/2025 | View on SEC |
| 8-K | 10/29/2025 | View on SEC |
| 3 | 10/22/2025 | View on SEC |
| 8-K | 10/17/2025 | View on SEC |
| SCHEDULE 13G/A | 8/12/2025 | View on SEC |
| 10-Q | 8/12/2025 | View on SEC |
| SCHEDULE 13G/A | 7/15/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OACCW |
| Company Name | Oaktree Acquisition Corp. III Life Sciences |
| CIK | 2029769 |
| Sector | Blank Checks |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 6770 |
| SIC Description | Blank Checks |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | E9 |
| Phone | 213-830-6300 |